Vavra Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$422K Hold
365
– – 0.37% 21
2026
Q2
$438K Hold
365
– – 0.38% 22
2026
Q1
$336K Hold
365
– – 0.33% 22
2025
Q4
$392K Buy
+365
New +$349K 0.39% 21

Other funds holding LLY

Vavra Capital Management's LLY Position: Q3 2026 in Review

Vavra Capital Management held its Eli Lilly (LLY) position steady in Q3 2026 at 365 shares worth $422K. The position accounts for 0.37% of the portfolio, ranked #21.

Vavra Capital Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $438K in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Vavra Capital Management held 365 shares of Eli Lilly worth $422K as of Q3 2026.
  • Vavra Capital Management left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.37% of Vavra Capital Management's portfolio in Q3 2026, its #21 holding.
  • Vavra Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Vavra Capital Management's Eli Lilly position peaked at $438K in Q2 2026.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Vavra Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.